Cargando…
Identification of novel immune checkpoints as targets for cancer immunotherapy
Autores principales: | Levy, Ofer, Toporic, Amir, Cojocaru, Gady, Dassa, Liat, Vaknin, Ilan, Kfir, Tal Fridman, Barbiro, Inbal, Neria, Eyal, Machlenkin, Arthur, Liang, Spencer, Sameach-Greenwald, Shirley, Levin, Zurit, Rotman, Galit, Hunter, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288399/ http://dx.doi.org/10.1186/2051-1426-2-S3-P110 |
Ejemplares similares
-
Computational discovery and experimental validation of novel drug targets in immuno-oncology
por: Levy, Ofer, et al.
Publicado: (2015) -
Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Rotman, Galit, et al.
Publicado: (2013) -
S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Cojocaru, G, et al.
Publicado: (2014) -
A slowly cleaved viral signal peptide acts as a protein-integral immune evasion domain
por: Seidel, Einat, et al.
Publicado: (2021) -
The Novel Mas agonist, CGEN-856S, Attenuates Isoproterenol-Induced Cardiac Remodeling and Myocardial Infarction Injury in Rats
por: Savergnini, Sílvia Q., et al.
Publicado: (2013)